Their hope is that such a drug would be precious to patients with ischemicstrokes and, unlike clot-buster drugs, harmless to those with hemorrhagic strokes.
It is also a potent risk factor for ischemic stroke, increasing the risk of stroke 5-fold and accounting for approximately 15% of all strokes nationally.